The inhibition of TNK-t-PA by C1-inhibitor

Blood Coagulation and Fibrinolysis

Volumn 12, Issue 1, 2001, Pages 75-77

  Sulikowski, T ^a   Patston, P A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

C1 inhibitor; Fibrinolysis; Serpin; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; COMPLEMENT COMPONENT C1S INHIBITOR; FIBRIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR DERIVATIVE;

ARTICLE; COMPLEX FORMATION; DRUG HALF LIFE; DRUG INHIBITION; DRUG SELECTIVITY; FIBRINOLYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; STOICHIOMETRY; ZYMOGRAPHY;

COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C1 INHIBITOR PROTEIN; CYSTEINE PROTEINASE INHIBITORS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; KINETICS; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0035124858     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200101000-00011     Document Type: Article

References (17)

1. A slow clearing, fibrin specific, PAI-1 resistant variant of t-PA (T103N, KHRR 296-299 AAAA)
2. A faster acting and more potent form of tissue plasminogen activator
3. TNK-tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 10A dose-ranging trial
4. Pharamacokinetics of a slower clearing tissue plasminogen activator variant, TNK-tPA, in patients with acute myocardial infarction
5. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor
6. Plasminogen activator in normal subjects after exercise and venous occlusion: t-PA circulates as complexes with C1-inhibitor and PAI-1
7. Interactions of tissue-type plasminogen activator with plasma inhibitor and their pharmacologic implications
8. 2-macroglobulin, and C1-inhibitor: Studies with defribination and a fibrinolytic state after electroshock or complicated labor
9. Enzymatic properties of the one- and two-chain form of tissue plasminogen activator
10. On the role of C1-inhibitor as inhibitor of tissue-type plasminogen activator in human plasma
11. The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine
12. 1-antitrypsin mutants against proteolytic enzymes of the kallikreinkinin, complement, and fibrinolytic systems
13. Fatal ischaemic oedema after early thrombolysis with tissue plasminogen activator in acute stroke
14. Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis
15. Angioedema during therapy with recombinant tissue plasminogen activator
16. Asymmetric angioneurotic edema associated with thrombolysis for acute stroke
17. Pathogenetic and clinical aspects of C1 inhibitor deficiency